Shayana Pharmaceuticals to Invest in GMP-Standard Drug Production in Uzbekistan

Tashkent, Uzbekistan (UzDaily.com) — A new investment project involving Shayana Pharmaceuticals will be implemented within the Tashkent Pharma Park pharmaceutical cluster.

The initiative, supported by the Agency for the Development of the Pharmaceutical Industry, envisions the establishment of a modern manufacturing facility fully compliant with international GMP standards.

The new plant will produce sterile injectable drugs in ampoules and vials, as well as solid dosage forms such as tablets and capsules.

The project is expected to create around 350 new jobs in the pharmaceutical sector, enhance production capacity, introduce advanced technologies, and supply the domestic market with locally manufactured medicines.

In addition, the initiative aims to strengthen the investment attractiveness of Uzbekistan’s pharmaceutical industry.